News
As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...
A Food and Drug Administration panel on Monday discussing the use of antidepressants during pregnancy largely amounted to ...
Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater than currently accepted.
Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...
(The Center Square) – Doctors on Monday urged the U.S. Food and Drug Administration to issue warnings to pregnant women ...
Some women’s symptoms improved quickly after taking the pill, but depression persisted in others. Doctors are trying to learn ...
Positive data on depression treatment based on a drug related to the psychedelic DMT is breathing life into shares of biotechs working on psychedelic medicines, after years of disappointments. Just as ...
In biggest advance for depression in years, FDA approves novel treatment for hardest cases. The nasal spray works in a new way and is based on an old anesthetic, ketamine, that has been used as a ...
The first drug for severe postpartum depression has been approved by the Food and Drug Administration. Thousands of women could benefit from the drug, but there are drawbacks, including a $35,000 ...
The Food and Drug Administration on Friday approved the first pill to treat postpartum depression, a condition that data shows affects around 1 in 7 women in the United States. Health experts say ...
The science of serotonin was largely a bust, too, despite billions in government research funding. The drug that had seemed so likely to provide a key to unlocking the biology of depression — an ...
NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results